NEW YORK (GenomeWeb News) – Roche today said that it will collaborate with SeqWright and the University of Miami Miller School of Medicine on identifying possible genetic variants associated with dilated cardiomyopathy.
The collaboration will employ NimbleGen's Sequence Capture Human Exome Arrays to enrich more than 180,000 exons from DNA samples taken from people with dilated cardiomyopathy, said Roche. SeqWright will sequence the enriched exons using 454 Life Sciences' Genome Sequencer FLX to detect SNPS, insertions, and deletions.